Primary Record
GSK126
- In stock
- 9,193 g
- Purity
- 98.4 %
- CAS
- 1346574-57-9
Compound Identifiers & Properties
- CAS
- 1346574-57-9
- PubChem CID
- 68210102
- SMILES
- CC[C@H](C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C
- Canonical SMILES
- CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3ccc(N4CCNCC4)nc3)cc21
Names & Synonyms
- GSK126
- 1346574-57-9
- GSK-126
- EZH2 inhibitor
- GSK 126
- GSK2816126
- W4OGW9QZ97
- RefChem:1086196
- D07TNE
- GSK126 HCl
- UNII-W4OGW9QZ97
- C31H38N6O2
- GSK-126 HCl
- CHEMBL3287735
- MLS006010251
- FKSFKBQGSFSOSM-QFIPXVFZSA-N
- GSK-2816126
- GTPL7012
- orb1306533
- SCHEMBL12180401
- SCHEMBL29352969
- AOB1764
- EX-A499
- SYN5012
- CHEBI:124921
- EZH2 Inhibitor GSK2816126
- GSK-2816126A
- MFCD23381067
- DTXSID301025739
- BCP06129
- GSK-126?
- KS-00000XH6
- (S)-1-(sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide
- BDBM50017293
- NSC780041
- NSC789702
- s7061
- ZINC72318146
- AKOS027322309
- CCG-269895
- CS-1401
- FB43076
- GSK 2816126 [WHO-DD]
- NSC-780041
- NSC-789702
- QC-9703
- NCGC00347286-01
- AS-16379
- BC600501
- CID:68210102
- HY-13470
- SC-94427
- SMR004701327
- SID:255511824
- AB0032512
- A3446
- X5824
- J3.125.295D
- A11757
- W-6022
- A857294
- C577920
- 1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide
- BRD-K21867462-001-02-9
- BRD-K21867462-001-03-7
- Q27077865
- 1346574-57-9 (GSK126)
- B1370-107617
- 1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3-methyl-6-[6-(piperazin-1-yl)pyridin-3-yl]-1H-indole-4-carboxamide
- 1H-Indole-4-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-3-methyl-1-((1S)-1-methylpropyl)-6-(6-(1-piperazinyl)-3-pyridinyl)-
- Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126
- N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide
- S)-1-(sec-butyl)-N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide
- N-((1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-3-methyl-1-((1S)-1-methylpropyl)-6-(6-(1-piperazinyl)-3-pyridinyl)-1H-indole-4-carboxamide
- N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide
- EZH2 inhibitor;GSK-126;GSK 126;GSK2816126A;GSK-2816126A;GSK 2816126A
- (S)-1-(sec-butyl)-N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-car boxamide
- (S)-1-sec-butyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide
- 1-((2S)-2-Butanyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl)-3-methyl-6-(6-(1-piperazinyl)-3-pyridinyl)-1H-indole-4-carboxamide
- 1-[(2S)-2-Butanyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide
- 1-[(2S)-BUTAN-2-YL]-N-[(4,6-DIMETHYL-2-OXO-1H-PYRIDIN-3-YL)METHYL]-3-METHYL-6-[6-(PIPERAZIN-1-YL)PYRIDIN-3-YL]INDOLE-4-CARBOXAMIDE
- 1419101-48-6
- 1H-Indole-4-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-
- A9G
- N-[(4,6-Dimethyl-2-oxo-1,2-dihydropyridine-3-yl)methyl]-3-methyl-1-[(S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridyl]-1H-indole-4-carboxamide